![A Comprehensive Review of PCSK9 Inhibitors - Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh, 2022 A Comprehensive Review of PCSK9 Inhibitors - Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh, 2022](https://journals.sagepub.com/cms/10.1177/10742484221100107/asset/images/large/10.1177_10742484221100107-fig2.jpeg)
A Comprehensive Review of PCSK9 Inhibitors - Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh, 2022
![A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α - eBioMedicine A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α - eBioMedicine](https://www.thelancet.com/cms/attachment/e928f8d7-3106-4025-9492-9f870171f3a2/gr1_lrg.jpg)
A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α - eBioMedicine
![PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review | Journal of the American Heart Association PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/5110678a-f25d-49c4-8f06-1bfbb0eed0fe/jah33256-fig-0001.png)